Authors:

I G. P. Supadmanaba, I. B. T. Wibawa-Manuaba

Abstract:

“Cancer is the second leading cause of death worldwide with continues rise mortality rate. Current cancer treatment modalities are still ineffective and associated with many side effects leading to robust research to find new specific target therapy. Heat shock factor (HSF)-1 is heat shock response mediator protein and act as transcription factor for HSP encoding gene. Many cancers have up-regulated HSP as a result of increase HSF-1 expression. Interestingly, inhibition of HSF-1 has no effect to normal cell, indicating HSF-1 as promises target therapy. RNAi is potential mechanism to block and down regulate HSF-1 which will affect many cellular processes in cancer cell. Combining RNAi base treatment with oncolityc viruses will boost the therapeutic effect of this novel treatment. Despite its potency, this modality still need further research in order to evaluate its efficacy and optimal doses to gain optimal result.”

Keywords

Keyword Not Available

Downloads:

Download data is not yet available.

References

References Not Available

PDF:

https://jurnal.harianregional.com/ijbs/full-6080

Published

2013-01-02

How To Cite

SUPADMANABA, I G. P.; WIBAWA-MANUABA, I. B. T.. A NOVEL APPROACH OF VIROTHERAPY BASED HSF-1 shRNA IN CANCER ERADICATION.INDONESIAN JOURNAL OF BIOMEDICAL SCIENCES, [S.l.], v. 7, n. 1, p. 11-22, jan. 2013. ISSN 2302-2906. Available at: https://jurnal.harianregional.com/ijbs/id-6080. Date accessed: 28 Aug. 2025.

Citation Format

ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian

Issue

Vol 7 No 1 (2013): IJBS Vol.7 No.1 January-June 2013

Section

Articles

Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License